OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
Marta Novella-Navarro, José Luis Cabrera-Alarcón, Natalia López-Juanes, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003382-e003382
Open Access | Times Cited: 6
Marta Novella-Navarro, José Luis Cabrera-Alarcón, Natalia López-Juanes, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003382-e003382
Open Access | Times Cited: 6
Showing 6 citing articles:
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender
Nicoletta Luciano, Elisa Barone, Enrico Brunetta, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Nicoletta Luciano, Elisa Barone, Enrico Brunetta, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
The concept of difficult-to-treat disease in rheumatology: where next?
György Nagy, Lilla Gunkl-Tóth, András M Dorgó, et al.
The Lancet Rheumatology (2025)
Closed Access
György Nagy, Lilla Gunkl-Tóth, András M Dorgó, et al.
The Lancet Rheumatology (2025)
Closed Access
Persistently different patterns of patient’s global assessment of health in rheumatoid arthritis are associated with pain and impaired function more than with inflammation: an inception cohort study over 15 years
Sidona‐Valentina Bala, Ingiäld Hafström, Björn Svensson, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e004744-e004744
Open Access
Sidona‐Valentina Bala, Ingiäld Hafström, Björn Svensson, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e004744-e004744
Open Access
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis
Marta Novella-Navarro, Virginia Ruiz‐Esquide, Natalia López-Juanes, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 9, pp. 2817-2823
Closed Access | Times Cited: 2
Marta Novella-Navarro, Virginia Ruiz‐Esquide, Natalia López-Juanes, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 9, pp. 2817-2823
Closed Access | Times Cited: 2
Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?
Zonne L. M. Hofman, Nadia M T Roodenrijs, Elena Nikiphorou, et al.
Lara D. Veeken (2024) Vol. 64, Iss. 1, pp. 65-73
Open Access | Times Cited: 1
Zonne L. M. Hofman, Nadia M T Roodenrijs, Elena Nikiphorou, et al.
Lara D. Veeken (2024) Vol. 64, Iss. 1, pp. 65-73
Open Access | Times Cited: 1
Real-World Assessment of the efficacy and tolerability profile of JAK Inhibitors in Difficult-to-Treat Rheumatoid Arthritis
Omar Al Tabaa, Sophie Hecquet, M. Thomas, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 69, pp. 152572-152572
Open Access
Omar Al Tabaa, Sophie Hecquet, M. Thomas, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 69, pp. 152572-152572
Open Access
